JP2007503941A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007503941A5 JP2007503941A5 JP2006525594A JP2006525594A JP2007503941A5 JP 2007503941 A5 JP2007503941 A5 JP 2007503941A5 JP 2006525594 A JP2006525594 A JP 2006525594A JP 2006525594 A JP2006525594 A JP 2006525594A JP 2007503941 A5 JP2007503941 A5 JP 2007503941A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- branched
- linear
- cycloalkyl
- oxygen atom
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0320441.9A GB0320441D0 (en) | 2003-09-02 | 2003-09-02 | Organic compounds |
| PCT/CH2004/000525 WO2005021051A1 (en) | 2003-09-02 | 2004-08-20 | Aminoalkyl substituted esters and amides of fumaric acid for neutralising malodor |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007503941A JP2007503941A (ja) | 2007-03-01 |
| JP2007503941A5 true JP2007503941A5 (enExample) | 2007-10-04 |
Family
ID=28686706
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006525594A Pending JP2007503941A (ja) | 2003-09-02 | 2004-08-20 | 悪臭中和用のフマル酸のアミノアルキル置換エステルおよびアミド |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US7638118B2 (enExample) |
| EP (1) | EP1735267B1 (enExample) |
| JP (1) | JP2007503941A (enExample) |
| CN (1) | CN100402095C (enExample) |
| AT (1) | ATE402137T1 (enExample) |
| BR (1) | BRPI0413878A (enExample) |
| DE (1) | DE602004015335D1 (enExample) |
| ES (1) | ES2309545T3 (enExample) |
| GB (1) | GB0320441D0 (enExample) |
| MX (1) | MXPA06002099A (enExample) |
| WO (1) | WO2005021051A1 (enExample) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0501237D0 (en) * | 2005-01-21 | 2005-03-02 | Givaudan Sa | Organic compounds |
| GB0526279D0 (en) * | 2005-12-23 | 2006-02-01 | Givaudan Sa | Improvements in or related to organic compounds |
| RU2554347C2 (ru) | 2008-08-19 | 2015-06-27 | Ксенопорт, Инк. | Пролекарства метилгидрофумарата, фармацевтические композиции с ними и способы применения |
| US8741275B2 (en) | 2010-06-04 | 2014-06-03 | Robetet, Inc. | Malodor neutralizing compositions comprising undecylenic acid or citric acid |
| WO2012103004A1 (en) | 2011-01-27 | 2012-08-02 | Robertet, Inc. | Malodor neutralizing compositions comprising bornyl acetate or isobornyl acetate |
| US9126890B2 (en) * | 2011-10-20 | 2015-09-08 | International Flavors & Fragrances Inc. | Low volatile reactive malodor counteractives and methods of use thereof |
| JP5918395B2 (ja) | 2012-02-07 | 2016-05-18 | ゼノポート，インコーポレイティド | モルホリノアルキルフマレート化合物、医薬組成物及び使用方法 |
| US9114180B2 (en) | 2012-03-30 | 2015-08-25 | Robertet, Inc. | Malodor neutralizing compositions containing acids and alicyclic ketones |
| CA2882730C (en) | 2012-08-22 | 2019-12-31 | Arbor Pharmaceuticals, Llc | Oral dosage forms of methyl hydrogen fumarate and prodrugs thereof |
| US10945984B2 (en) | 2012-08-22 | 2021-03-16 | Arbor Pharmaceuticals, Llc | Methods of administering monomethyl fumarate and prodrugs thereof having reduced side effects |
| KR102085557B1 (ko) | 2013-03-14 | 2020-03-06 | 엘커메스 파마 아일랜드 리미티드 | 푸마레이트의 프로드럭 및 다양한 질환을 치료하는데 있어서의 이들의 용도 |
| US8669281B1 (en) | 2013-03-14 | 2014-03-11 | Alkermes Pharma Ireland Limited | Prodrugs of fumarates and their use in treating various diseases |
| US10179118B2 (en) | 2013-03-24 | 2019-01-15 | Arbor Pharmaceuticals, Llc | Pharmaceutical compositions of dimethyl fumarate |
| US9302977B2 (en) | 2013-06-07 | 2016-04-05 | Xenoport, Inc. | Method of making monomethyl fumarate |
| US9421182B2 (en) | 2013-06-21 | 2016-08-23 | Xenoport, Inc. | Cocrystals of dimethyl fumarate |
| US9416096B2 (en) | 2013-09-06 | 2016-08-16 | Xenoport, Inc. | Crystalline forms of (N,N-Diethylcarbamoyl)methyl methyl (2E)but-2-ene-1,4-dioate, methods of synthesis and use |
| JP6337135B2 (ja) | 2014-02-24 | 2018-06-06 | アルカーメス ファーマ アイルランド リミテッド | フマル酸エステルのスルホンアミドプロドラッグ及びスルフィンアミドプロドラッグ並びに種々の疾患の治療におけるその使用 |
| US9999672B2 (en) | 2014-03-24 | 2018-06-19 | Xenoport, Inc. | Pharmaceutical compositions of fumaric acid esters |
| WO2016061393A1 (en) | 2014-10-15 | 2016-04-21 | Xenoport, Inc. | Fumarate compounds, pharmaceutical compositions, and methods of use |
| US10226544B2 (en) | 2015-06-05 | 2019-03-12 | International Flavors & Fragrances Inc. | Malodor counteracting compositions |
| CN118119372A (zh) * | 2021-10-20 | 2024-05-31 | 国际香料和香精公司 | 恶臭冲消化合物、组合物及其用途 |
| CN115043741A (zh) * | 2022-08-15 | 2022-09-13 | 江苏第二师范学院 | 一种全烷基取代的反丁烯二酸双氨基醇酯及其盐酸盐的制备方法 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3077457A (en) | 1960-04-15 | 1963-02-12 | Fritzsche Brothers Inc | Fumaric acid ester space deodorant and method of using same |
| GB969347A (en) | 1961-08-28 | 1964-09-09 | Fritzsche Brothers Inc | Deodorant compositions |
| GB1206359A (en) | 1968-08-02 | 1970-09-23 | Nii Monomerov Dlya Sint Kauchu | Method for production of aminoalkyl fumarates |
| DE1793142A1 (de) * | 1968-08-08 | 1972-02-24 | Nii Monomerow Dlja Sintetitsch | Verfahren zur Herstellung von Fumarsaeureaminoalkylestern und neue Aminoalkylester dieser Saeure |
| US3580918A (en) * | 1968-09-03 | 1971-05-25 | Nii Monomerov Dlya Sint | Method for the preparation of aminoalkyl fumarates |
| FR1588375A (enExample) | 1968-10-15 | 1970-04-10 | ||
| CH582003A5 (enExample) | 1972-07-12 | 1976-11-30 | Ciba Geigy Ag | |
| NL7807770A (nl) * | 1977-07-22 | 1979-01-24 | Naarden International Nv | Samenstelling met deodoriserende werking die een viny- lether bevat, alsmede vinylethers met deodoriserende werking. |
| JPH0657832B2 (ja) * | 1985-06-11 | 1994-08-03 | 大同化学工業株式会社 | 金属圧延油組成物 |
| US5601809A (en) | 1986-09-26 | 1997-02-11 | The Gillette Company | Axillary malodor neutralization |
| US5723558A (en) * | 1995-08-31 | 1998-03-03 | Nof Corporation | Fumaric acid derivative and polymer therefrom |
| US6610648B2 (en) | 2000-12-22 | 2003-08-26 | Givaudan Sa | Malodor counteractant compositions |
| AU2002349359A1 (en) * | 2001-12-20 | 2003-07-09 | Basf Aktiengesellschaft | Absorbent article |
-
2003
- 2003-09-02 GB GBGB0320441.9A patent/GB0320441D0/en not_active Ceased
-
2004
- 2004-08-20 JP JP2006525594A patent/JP2007503941A/ja active Pending
- 2004-08-20 ES ES04761873T patent/ES2309545T3/es not_active Expired - Lifetime
- 2004-08-20 AT AT04761873T patent/ATE402137T1/de not_active IP Right Cessation
- 2004-08-20 MX MXPA06002099A patent/MXPA06002099A/es active IP Right Grant
- 2004-08-20 US US10/569,990 patent/US7638118B2/en not_active Expired - Fee Related
- 2004-08-20 CN CNB2004800251146A patent/CN100402095C/zh not_active Expired - Fee Related
- 2004-08-20 WO PCT/CH2004/000525 patent/WO2005021051A1/en not_active Ceased
- 2004-08-20 BR BRPI0413878-3A patent/BRPI0413878A/pt not_active IP Right Cessation
- 2004-08-20 DE DE602004015335T patent/DE602004015335D1/de not_active Expired - Lifetime
- 2004-08-20 EP EP04761873A patent/EP1735267B1/en not_active Expired - Lifetime
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2007503941A5 (enExample) | ||
| RU2470910C9 (ru) | Соединения, представляющие собой алкинилфенильные производные, для лечения офтальмических заболеваний и расстройств | |
| JP2005508293A5 (enExample) | ||
| JP2009524691A5 (enExample) | ||
| JP2006522035A5 (enExample) | ||
| JP2009519993A5 (enExample) | ||
| JP2008115170A5 (enExample) | ||
| JP2014506907A5 (enExample) | ||
| JP2004506661A5 (enExample) | ||
| JP2008517030A5 (enExample) | ||
| JP2009543795A5 (enExample) | ||
| JP2002539181A5 (enExample) | ||
| JP2010520243A5 (enExample) | ||
| CA2336412A1 (en) | Medicament for treatment of diabetes | |
| JP2008512408A5 (enExample) | ||
| JP2006523241A5 (enExample) | ||
| ATE450496T1 (de) | Verbindungen zur behandlung von stoffwechselstörungen | |
| JP2005505583A5 (enExample) | ||
| JP2004535380A5 (enExample) | ||
| JP2017534639A5 (enExample) | ||
| JP2005510457A5 (enExample) | ||
| JP2011093883A5 (enExample) | ||
| JP2004517151A5 (enExample) | ||
| HRP20210211T1 (hr) | Triazoli namijenjeni reguliranju homeostaze unutarstaničnog kalcija | |
| JP2004331662A5 (enExample) |